Results 151 to 160 of about 49,826 (161)

Biology of Human Sodium Glucose Transporters

Physiological Reviews, 2011
Ernest M Wright
exaly  

Sodium-glucose co-transporter 2 inhibitor associated normoglycaemic ketoacidosis

Endocrine Abstracts, 2015
Shane Bobart, Benjamin Gleason, Jonathan Schroeder, Nydia Martinez, Keith Norris, Sandra Williams   +5 more
openaire   +1 more source

The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors

Metabolism: Clinical and Experimental, 2014
John P H Wilding
exaly  

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

Diabetes Care, 2015
Anne Peters Harmel, Irl B Hirsch
exaly  

Radix-glycyrrhizae/Sodium-glucose transporter 2 inhibitors

Reactions Weekly
openaire   +1 more source

Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists

Circulation, 2016
Jacob A Udell, David Z I Cherney
exaly  

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

Endocrine Reviews, 2011
Luke Norton, Ralph A Defronzo
exaly  

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

European Journal of Heart Failure, 2019
John J V Mcmurray, David L Demets, Lars Køber   +2 more
exaly  

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation
Yu Mi Kang, Stefan D Anker, Deepak L Bhatt   +2 more
exaly  

Renal Sodium-Glucose Transporter-2 Inhibitors as Antidiabetic Agents

2018
Anand S. Nair, Debasis Bagchi, Teresa E. Lehmann, Sreejayan Nair   +3 more
openaire   +1 more source